ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
Clinical trials for ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody therapy aims to stop chronic kidney transplant rejection
Disease control Recruiting nowThis trial tests a bispecific T-cell engager (BiTE) antibody in kidney transplant recipients who have chronic active antibody-mediated rejection (cAMR). The BiTE targets BCMA and CD3 to deplete harmful B cells and plasma cells that produce donor-specific antibodies. Researchers w…
Matched conditions: ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: Turun Song • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Scientists probe why Anti-B cell therapies fail in kidney rejection
Knowledge-focused Recruiting nowThis study looks at why some kidney transplant rejections don't respond to treatments that target B cells. Researchers will collect blood, stool, and kidney tissue from 45 patients to study B cell behavior and antibody reactions. The goal is to uncover the hidden triggers of reje…
Matched conditions: ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC